Amgen (AMGN) PT Raised to $272 at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Amgen (AMGN) tops profit expectations, revenue rises 5%
October 31, 2023 7:58 AM EDTAmgen (NASDAQ: AMGN) reported earnings for its latest quarter on Tuesday, topping consensus profit expectations and raising guidance.
The company reported Q3 EPS of $4.96, $0.28 better than the analyst estimate of $4.68, while revenue for the quarter came in at $6.9 billion, up 4% YoY but slightly... More
